Phase 3 Study of the Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections Among Colorectal Surgery Patients (Triple IN Study-INhibition of INcisional INfections)

Next Previous
Trial Profile

Phase 3 Study of the Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections Among Colorectal Surgery Patients (Triple IN Study-INhibition of INcisional INfections)

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Sep 2017

At a glance

  • Drugs E 101 (Primary)
  • Indications Bacterial infections; Postoperative infections; Viral infections
  • Focus Registrational; Therapeutic Use
  • Acronyms Triple IN

    • Most Recent Events

    • 16 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 16 Sep 2015 Planned primary completion date changed from 1 Mar 2016 to 1 Oct 2015 as reported by ClinicalTrials.gov.
    • 20 Nov 2014 Planned End Date changed from 1 Nov 2014 to 1 Jun 2016, according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top